BIT 7.53% 10.0¢ biotron limited

BIT Interesting

  1. 8,034 Posts.
    Two academics from a prestigious Australian medical research centres are clashing over a prospectus claim. The issue involves the float on 24 January of Biotron, a medical research company, founded by John Curtin School of Medical Research (JCSMR) professor, Peter Gage. Biotron's prospectus, used to raise $A12 million, refers to the development of anti-viral agents to block ion channels that carry viruses, such as those causing dengue and Ross River fevers. Fellow JCSMR professor, Graeme Laver, from the institute's biochemistry and molecular biology division, has complained to the Australian Securities and Investments Commission that there is no proof these particular viruses possess ion channels

    The claim was dismissed because it did not contavene ASIC guidelines but what about the Ion exchange?
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Mkt cap ! $70.19M
Open High Low Value Volume
9.4¢ 10.3¢ 9.4¢ $522.7K 5.285M

Buyers (Bids)

No. Vol. Price($)
3 229359 10.0¢

Sellers (Offers)

Price($) Vol. No.
10.5¢ 1337185 24
View Market Depth
Last trade - 16.10pm 27/05/2022 (20 minute delay) ?
0.007 ( 8.23 %)
Open High Low Volume
9.4¢ 10.0¢ 9.4¢ 1949260
Last updated 15.59pm 27/05/2022 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.